CCI4EU - Molecular diagnostics and precision medicine

MATERIALS AVAILABLE

CCI4EU - Molecular diagnostics and precision medicine

MATERIALS AVAILABLE

Chairs: Anna Sapino, IT - Olli Carpen, FI - Rui Henrique, PT

Introduction

CCI4EU (Comprehensive Cancer Infrastructures for the European Union) is a European project aiming to help Member States and Associated Countries improve or develop their existing or future Comprehensive Cancer Infrastructures (CCIs), by helping develop their research & innovation-related capacities.

This course is one of 10 online training courses organised within the project to help countries develop an effective comprehensive infrastructure and widen the reach of this grant. The topic of this online course is Molecular diagnostics and precision medicine.

Target audience
Pathologists, researchers, management, coordinators, patient advocates.

Course delivery

This online course was held live on 4th December via this webpage. The entire course was recorded and is now available as on-demand material.

To access the on-demand materials (after the live streaming), participants must register to the course, login to the e-ESO platform and click on the play buttons inside the course programme.

Official language

The course was held in English. Translations are not provided, but English subtitles can be activated and transcriptions can be automatically translated using free online tools.

Registration

Registration to the course is free but mandatory.

Certificate of attendance

Participants (both live and on-demand) will be issued a certificate of attendance once they have completed a minimum attendance of 75% of the entire course. An online evaluation questionnaire must be completed in order to receive the certificate that will be issued by email. The evaluation questionnaire will appear in the right-hand column of the course page when participants have completed the course.

Organising secretariat

Sarah Goldman: sgoldman@eso.net

Francesca Marangoni: fmarangoni@eso.net

Sonia Bulgarelli: sbulgarelli@eso.net

04/12/2024

LIVE STREAMING

04/12/2024

Welcome and introduction

Olli Carpén (FI) Rui Henrique (PT) Anna Sapino (IT)

04/12/2024

Opportunistic genetic screening for breast cancer predisposition

Minja Pehrsson (FI)

Discussion

Olli Carpén (FI) Minja Pehrsson (FI)

04/12/2024

Molecular Diagnostics and precision medicine

Molecular Diagnostics: where we are today: aim, techniques

Umberto Malapelle (IT)

Molecular Diagnostics: where we are going in the future

Albrecht Stenzinger (DE)

Practical Implementations: what is needed, coordination, resources, delivery, budgets, challenges

Discussion

Marius Ilié (FR) Umberto Malapelle (IT) Caterina Marchiò (IT) Albrecht Stenzinger (DE)

04/12/2024

Molecular Tumour Boards

The Importance of Molecular Tumour Boards

Laura Mezquita (ES)

How to create/implement/co-ordinate Molecular Tumour Boards

Rodrigo Dienstmann (ES)

Molecular Tumour Boards: Protocols and Regulations

Discussion

Sigmund Brabrand (NO) Gennaro Ciliberto (IT) Rodrigo Dienstmann (ES) Laura Mezquita (ES)

04/12/2024

BREAK

04/12/2024

Financial issues in precision medicine

Case 1 - Example reimbursement model

Bengt Jönsson (SE)

Case 2 - Example reimbursement model

Nicola Normanno (IT)

Discussion on sustainability: pros, cons and challenges

Bengt Jönsson (SE) Nicola Normanno (IT)

04/12/2024

Patient advocate

The importance of patient advocates to implement molecular diagnostics and precision medicine

Bettina Ryll (SE)

Discussion

Rui Henrique (PT) Bettina Ryll (SE)

04/12/2024

Clinical Trials in precision medicine

Ongoing clincial trials in place

Åslaug Helland (NO)

Future of clinical trials

Vanesa Gregorc (IT)

Discussion

Vanesa Gregorc (IT) Åslaug Helland (NO)

04/12/2024

Closing remarks

Olli Carpén (FI) Rui Henrique (PT) Anna Sapino (IT)

Albrecht Stenzinger

Heidelberg University Hospital, , Heidelberg, DE

Anna Sapino

IRCCS Istituto di Candiolo, Dept. of Pathology, Candiolo, IT

Åslaug Helland

Oslo universitetssykehus HF - Oslo University Hospital, Institute of Clinical Medicine, Oslo, NO

Bengt Jönsson

Stockholm School of Economics, Economics Dept., Stockholm, SE

Bettina Ryll

Melanoma Patient Network Europe, Patient Advocacy Dpt., Uppsala, SE

Caterina Marchiò

FPO Istituto di Ricovero e Cura a Carattere Scientifico, Dip. di Scienze Mediche, Candiolo, IT

Gennaro Ciliberto

Istituto Nazionale Tumori Regina Elena, Scientific Directorate, Rome, IT

Laura Mezquita

University of Barcelona, Laboratory of Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, ES

Marius Ilié

, , ,

Minja Pehrsson

, , ,

Nicola Normanno

ITN - IRCCS G. Pascale Foundation, Cell Biology and Biotherapy Unit, Napoli, IT

Olli Carpén

University of Helsinki, Department of Pathology, Helsinki, FI

Rodrigo Dienstmann

Vall d’Hebron Institute of Oncology, Molecular Therapeutic Research Unit, Barcelona, ES

Rui Henrique

Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E., Pathological Anatomy Service, Porto, PT

Sigmund Brabrand

, , ,

Umberto Malapelle

University of Naples Federico II, Dpt. of Public Health, NAPOLI, IT

Vanesa Gregorc

Istituto di Candiolo IRCC, Dept. of Oncology, Torino, IT

Molecular and cellular oncology Oncology practice and communication Targeted therapies and cancer pharmacology

ONLINE COURSE

04

Dec
2024

This course is part of:

Funded by: funded by the european union